Amikacin Sulphate Injection belongs to aminoglycoside class of drugs with targeted mode of action and high effectiveness. It is antibiotic which is prescribed for treatment of urinary tract infection, meningitis, sepsis, and pneumonia. Upon administration, it binds to 30s subunit of bacterial ribosome and interferes with protein synthesis. This injection is administered via intramuscular or intravenous route by trained physician. It has bioavailability of more than 90% with protein binding ability of up to 11%. Amikacin Sulphate Injection has shown superior effectiveness even for multi-drug resistant bacteria including aerobic gram-negative strains. It gets excreted from kidney with elimination half life of 2-3 hours.